The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat ...

Meta's Llama Large Language Model ( LLM) had a vulnerability which could have allowed threat actors to execute arbitrary code ...

Disease-reversal startup Retro Biosciences is aiming for a $1 billion funding round, a spokesperson for the company confirmed ...

The Massachusetts based biotech will now press ahead with human trials for its antisense oligonucleotide (ASO) therapy, ...

Scientists recently studied how different factors affect antisense oligonucleotides (ASOs) under hydrophilic interaction ...

HHS Secretary nominee Robert F. Kennedy Jr. will divest his interests in several biopharma companies, including CRISPR ...

By Dr. Priyom Bose, Ph.D. Lifestyle modifications alleviate polycystic ovary syndrome (PCOS) by improving biochemical, ...

The 2022 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Avidity, or following a bona fide period of non-employment, as an ...

Massachusett-based Stoke Therapeutics STOK is making rapid progress with the development of zorevunersen (STK-001), its ...

AI art is seemingly everywhere online. These images are made by AI generators, programs that use generative AI to take your simple text description and transform it into a batch of images that ...

Getty Images Holdings Inc. is exploring a combination with rival Shutterstock Inc., according to people familiar with the matter. Shares Getty Images rose as much as 32%, the most since 2023.

Jan 3 (Reuters) - Getty Images Holdings (GETY.N), opens new tab is exploring a merger with its rival Shutterstock (SSTK.N), opens new tab, Bloomberg News reported on Friday, citing people familiar ...